0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Screening and Detection of Breast Cancer and Prostate Cancer

Marc B. Garnick, MD
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.275.
Text Size: A A A
Published online

Extract

To the Editor: Dr Esserman and colleagues1 provided lucid and compelling reasons to challenge the current methods of screening for prostate and breast cancers and correctly concluded that “tumor biology dictates and trumps stage, so the basic assumption . . . that finding and treating early stage disease will prevent late stage or metastatic disease may not always be correct.” In the examples cited, early detection and treatment rarely prevent the development of metastatic disease, as evidenced by large screening studies in both prostate and breast cancer.2 However, hypothetical tumor C (one benefiting from screening) in Figure 3 is misleading and, as interpreted, will do little to change the status quo of inappropriately treating indolent cancers that are still “localized to organ.”

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

March 17, 2010
Emmanuel Saloustros, MD; Dimitris Mavroudis, MD
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.273.
March 17, 2010
Nigel Paneth, MD, MPH; George Vande Woude, PhD; Eric Kort, MD, MSc
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.274.
March 17, 2010
Laura Esserman, MD, MBA; Ian Thompson, MD
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.276.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();